Detalles de la búsqueda
1.
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
N Engl J Med
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785209
2.
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo.
Kidney Int
; 103(4): 772-781, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738891
3.
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
Cardiovasc Diabetol
; 22(1): 220, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620807
4.
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
Nephrol Dial Transplant
; 38(9): 2041-2051, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651820
5.
Influence of Production Process and Scale on Quality of Polypeptide Drugs: a Case Study on GLP-1 Analogs.
Pharm Res
; 37(7): 120, 2020 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514880
6.
Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population.
Diabetes Obes Metab
; 21(8): 1837-1848, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30945402
7.
Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.
Diabetes Obes Metab
; 21(3): 525-532, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260088
8.
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial.
Diabetes Obes Metab
; 21(11): 2450-2458, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31282028
9.
The authors reply.
Kidney Int
; 104(3): 619, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599024
10.
Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
Circulation
; 138(15): 1605-1607, 2018 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30354517
11.
A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg.
J Diabetes Investig
; 13(8): 1321-1329, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285173
12.
Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population.
Diabetes Metab Syndr Obes
; 14: 2619-2629, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34140791
13.
Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of a phase 3 randomized clinical trial.
J Diabetes Investig
; 9(4): 840-849, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277968
14.
Safety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post-hoc analysis of a randomized, 52-week, open-label, parallel-group trial.
J Diabetes Investig
; 9(4): 831-839, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28984041
15.
Liraglutide and Glycaemic Outcomes in the LEADER Trial.
Diabetes Ther
; 9(6): 2383-2392, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30392095
16.
Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial.
J Diabetes Investig
; 7(1): 76-84, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26816604
17.
Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.
J Diabetes Investig
; 7(4): 565-73, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27182042
18.
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial.
Diabetes Care
; 39(9): 1501-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27311491
19.
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
Diabetes Care
; 39(2): 222-30, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26681713
20.
European regulation on orphan medicinal products: 10 years of experience and future perspectives.
Nat Rev Drug Discov
; 10(5): 341-9, 2011 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21532564
Resultados
1 -
20
de 20
1
Próxima >
>>